Tumor-associated chloride channel

Tumor-associated chloride channels (TACCs) represent a functional class of ion channels and regulatory proteins that are aberrantly expressed or activated in various malignancies. This group primarily includes members of the Anoctamin family (notably ANO1/TMEM16A), the Chloride Intracellular Channel family (CLIC1), and the Chloride Channel Accessory family (CLCA1, CLCA2). These channels play a critical role in tumor progression by regulating cell volume, which is essential for the morphological changes required during cancer cell migration and invasion. Additionally, they modulate key signaling pathways such as MAPK/ERK and PI3K/Akt, influencing cell proliferation and survival. Therapeutic strategies targeting TACCs include small-molecule inhibitors like Ani-7 and peptide-based toxins like Chlorotoxin (TM-601), which specifically bind to these channels or their associated complexes on tumor cells. While promising as targets for both therapy and diagnostic imaging (e.g., DOG1 in GIST), challenges remain regarding the selectivity of these agents and the potential for off-target effects on normal physiological processes like fluid secretion and muscle tone.

Other names

Calcium-activated chloride channel (CaCC)Chloride channel accessory (CLCA)Anoctamin-1 (ANO1)TMEM16ADOG1Chloride intracellular channel 1 (CLIC1)Lung-tumor-associated chloride channel (hCLCA1)Glioma-specific chloride channel

Inhibition of chloride ion conductance, modulation of cell volume changes required for migration, inhibition of matrix metalloproteinase-2 (MMP-2) activity, and disruption of oncogenic signaling pathways.